Stockreport

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF Synthetic alternative to traditional matrices, enabling consistent performance while aligning with regulatory and translational initiatives MINNEAPOLIS Feb. 2, 2026 / [Read more]